Applied DNA Sciences Inc. sell nvestor
Start price
15.10.22
/
50%
€2.38
Target price
15.10.23
€1.00
Performance (%)
-24.07%
End price
29.10.22
€1.81
Summary
This prediction ended on 29.10.22 with a price of €1.81. The prediction for Applied DNA Sciences Inc. closed with a convincing performance of -24.07%. nvestor has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Applied DNA Sciences Inc. | - | - | - |
iShares Core DAX® | 1.560% | 4.721% | 18.671% |
iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% |
iShares Nikkei 225® | 1.730% | 6.073% | 16.253% |
iShares S&P 500 | 1.482% | 1.218% | 23.290% |
According to nvestor what are the pros and cons of Applied DNA Sciences Inc. for the foreseeable future?
Pros
Cons
Significant cyclical dependencies
Little known brand
Revenue decline/stagnation expected
ROE lower than 10% per year
Few uniques
Business model of the past or high risk
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Comments by nvestor for this prediction
In the thread Applied DNA Sciences Inc. diskutieren
Sell mit Kursziel 1,0
In the thread Trading Applied DNA Sciences Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by nvestor for Applied DNA Sciences Inc.
Applied DNA Sciences Inc.
Start price
Target price
Perf. (%)
€10.10
09.01.21
09.01.21
€4.00
09.01.22
09.01.22
-42.08%
26.06.21
26.06.21
Significant cyclical dependencies
Little known brand
Revenue decline/stagnation expected
ROE lower than 10% per year